MedTrace Logo

Evaluation of an Herbal-Based De-Pigmenting System

NCT02138539 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2015-11-18

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness and tolerability of an herbal de-pigmenting regimen applied to one side of the face compared with hydroquinone applied to the other side of the face in treating mottled hyperpigmentation and melasma.

Conditions

  • Melasma
  • Hyperpigmentation

Interventions

OTHER

Herbal depigmenting agent (Epionce)

A two product herbal pigmentation reducing regimen is applied twice a day to either the left or right side of the face for a duration of 4 months.

DRUG

Hydroquinone

Hydroquinone 4% is applied twice a day to either the left or right side of the face for a duration of 4 months.

Sponsors & Collaborators

  • Episciences, Inc.

    collaborator INDUSTRY

  • Sadick Research Group

    lead OTHER

Principal Investigators

  • Neil S Sadick, MD · Sadick Research Group

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
SINGLE_GROUP

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2014-10-31
Completion
2014-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02138539 on ClinicalTrials.gov